Bavarian Nordic Announces Appointment of Henrik Juuel as Chief Financial Officer
May 31, 2018 02:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, May 31, 2018...
Bavarian Nordic Announces Interim Results for the First Three Months of 2018
May 24, 2018 01:41 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, May 24, 2018 -...
Bavarian Nordic offentliggør delårsregnskab for første kvartal 2018
May 24, 2018 01:41 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark, 24. maj 2018 - Bavarian...
Bavarian Nordics kræftvaccinekandidater præsenteres på American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2018 17:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark, 16. maj 2018 - Bavarian...
Bavarian Nordic Announces Acceptance of Abstracts and Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2018 17:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, May 16, 2018 - Bavarian...
Bavarian Nordic afholder telefonkonference i forbindelse med offentliggørelsen af regnskabet for første kvartal 2018
May 16, 2018 11:30 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, 16. maj 2018 - Bavarian Nordic A/S...
Bavarian Nordic to Host First Quarter 2018 Results Conference Call
May 16, 2018 11:30 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark - May 16, 2018 -...
Bavarian Nordic Receives FDA Orphan Drug Designation for BN-Brachyury for the Treatment of Chordoma
May 02, 2018 09:33 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Phase 2 Study in Metastatic Chordoma to...
Bavarian Nordic modtager orphan drug status fra de amerikanske sundhedsmyndigheder, FDA, for BN-Brachyury til behandling af chordoma-kræft
May 02, 2018 09:33 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Fase 2 forsøg i metastatisk chordoma...
Bavarian Nordic A/S - Vedtægter
May 01, 2018 09:49 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Opdaterede vedtægter for Bavarian Nordic A/S. ...